Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Experimental drugs
Lu AA-33810
Другие языки:

Lu AA-33810

Подписчиков: 0, рейтинг: 0
Lu AA-33810
Lu AA33810.svg
Clinical data
Other names Lu AA-33810
ATC code
  • None
Identifiers
  • N-[(trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl)methyl]methanesulfonamide
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
Formula C19H25N3O2S3
Molar mass 423.61 g·mol−1
3D model (JSmol)
  • O=S(C)(=O)NCC3CCC(CC3)Nc4sc2CCSc1ccccc1-c2n4
  • InChI=1S/C19H25N3O2S3/c1-27(23,24)20-12-13-6-8-14(9-7-13)21-19-22-18-15-4-2-3-5-16(15)25-11-10-17(18)26-19/h2-5,13-14,20H,6-12H2,1H3,(H,21,22)
  • Key:UWSBTSAJZMIHBL-UHFFFAOYSA-N
  (verify)

Lu AA-33810 is a drug developed by Lundbeck, which acts as a potent and highly selective antagonist for the Neuropeptide Y receptor Y5, with a Ki of 1.5nM and around 3300x selectivity over the related Y1, Y2 and Y4 receptors. In animal studies it produced anorectic, antidepressant and anxiolytic effects, and further research is now being conducted into its possible medical application in the treatment of eating disorders.



Новое сообщение